Silver Spring BioPharma Consulting

Silver Spring BioPharma Consulting is a regulatory and drug development consulting firm founded in late 2022 by Dr. Youmin (June) Wang, an experienced pharmaceutical scientist and former FDA senior reviewer. The company specializes in providing expert advice and support for FDA meetings—including pre-IND, end-of-phase meetings, and pre-NDA/BLA/ANDA interactions—as well as comprehensive guidance throughout the product development process for pharmaceutical companies, research organizations, API manufacturers, biopharmaceutical companies, CDMOs, and healthcare professionals. Services are tailored to improve regulatory confidence and effectiveness from ideation through approval.